Immunolocalization of apolipoprotein d, androgen receptor and prostate specific antigen in early stage prostate cancers

Journal of Urology

Volumn 159, Issue 2, 1998, Pages 548-554

  Zhang, Steven X D ^b   Bentel, Jacqueline M ^b   Ricciardelli, Carmela ^b   Horsfall, David J ^b   Haagensen, Darrow E ^b   Marshall, Villis R ^b   Tilley, Wayne D ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b NONE

Author keywords

Androgen receptor; Apolipoproteins; Immunohistochemistry; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

ANDROGEN RECEPTOR; APOLIPOPROTEIN D; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER STAGING; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0031964552     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63981-8     Document Type: Article

References (38)

1. Huggins, C. and Hodges, C. V.: Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1: 293, 1941.
2. Klein, E. A.: Hormone therapy for prostate cancer: a topical perspective. Urology, 47: 3, 1996.
3. Soloway, M. S., Sharifi, R., Wajsman, Z., McLeod, D., Wood, D. P. and Puras-Baez, A.: Randomized prospective study comparing radical prostatectomy preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. J. Urol., 154: 424, 1995.
4. Brawley, O. W. and Thompson, I. M.: Chemoprevention of prostate cancer. Urology, 43: 594, 1994.
5. Lubahn, D. B., Joseph, D. R., Sullivan, P. M., Willard, H. F., French, F. S. and Wilson, E. M.: Cloning of the human androgen receptor complementary DNA and localization to the X chromosome. Science, 240: 327, 1988.
6. Tilley, W. D., Marcelli, M., Wilson, J. D. and McPhaul, M. J.: Characterization and expression of a cDNA encoding the human androgen receptor. Proc. Natl. Acad. Sci. USA, 86: 327, 1989.
7. Husmann, D. A., Wilson, C. M., McPhaul, M. J., Tilley, W. D. and Wilson, J. D.: Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology, 126: 2359, 1990.
8. Bentel, J. M. and Tilley, W. D.: Androgen receptors in prostate cancer. J. Endocrinol., 151: 1, 1996.
9. Ruizeveld de Winter, J. A., Trapman, J., Brinkmann, A. O., Boersma, W. J. A., Mulder, E., Schroeder, F. H., Claasen, E. and van der Kwast, T. H.: Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J. Pathol., 161: 329, 1990.
10. Chodak, G. W., Kranc, D. M., Puy, L. A., Takeda, H., Johnson, K. and Chang, C.: Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. J. Urol., 147: 798, 1992.
11. Hobisch, A., Culig, Z., Radmayr, C., Bartsch, G., Klocker, H. and Hittmair, A.: Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res., 55: 3068, 1995.
12. Sadi, M. V. and Barrack, E. R.: Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Cancer, 71: 2574, 1993.
13. Tilley, W. D., Lim-Tio, S. S., Horsfall, D. J., Aspinall, J. O., Marshall, V. R. and Skinner, J. M.: Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res., 54: 4096, 1994.
14. Goldfarb, D. A., Stein, B. S., Shamszadeh, M. and Petersen, R. O.: Age-related changes in tissue levels of prostatic acid phosphatase and prostate specific antigen. J. Urol., 136: 1266, 1986.
15. Aspinall, J. O., Bentel, J. M., Horsfall, D. J., Haagensen, D. E., Marshall, V. R. and Tilley, W. D.: Differential expression of Apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues. J. Urol., 154: 622, 1995.
16. Dupont, A., Cusan, L., Gomez, J. L., Thibeault, M. M., Tremblay, M. and Labrie, F.: Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate. J. Urol., 146: 1064, 1991.
17. Abrahamsson, P. A., Lilja, H., Falkmer, S. and Wadstrom, L. B.: Immunohistochemical distribution of the three predominant secretory proteins in the parenchyme of hyperplastic and neoplastic prostate glands. Prostate, 12: 39, 1988.
18. Balbin, M., Freije, J. M., Fueyo, A., Sanchez, L. M. and Lopez, O. C.: Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease. Biochem. J., 271: 803, 1990.
19. Mazoujian, G. and Haagensen, D. E.: The immunopathology of gross cystic disease fluid proteins. Ann. N. Y. Acad. Sci., 586: 188, 1990.
20. Lea, O. A., Kvinnsland, S. and Thorsen, T.: Progesterone-binding cyst protein in human breast tumor cytosol. Cancer Res., 47: 6189, 1987.
21. Simard, J., Veilleux, R., de Launoit, Y., Haagensen, D. E. and Labrie, F.: Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells. Cancer Res., 51: 4336, 1991.
22. Simard, J., de Launoit, Y., Haagensen, D. E. and Labrie, F.: Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology, 130: 1115, 1992.
23. Poulin, R., Baker, D. and Labrie, F.: Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat., 12: 213, 1988.
24. López-Boado, Y. S., Tolivia, J. and López-Otin, C.: Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. J. Biol. Chem., 269: 26871, 1994.
25. Blais, Y., Sugimoto, K., Carriere, M-C., Haagensen, D. E., Labrie, F. and Simard, J.: Potent stimulatory effect of interleukin-1α on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells. Int. J. Cancer, 59: 400, 1994.
26. Khoury, S.: Staging of prostate cancer. In: Urology: Prostate Cancer. Edited by S. Khoury, C. Chatelain, G. Murphy and L. Denis. Boissy-le-Cutté, France: F. I. I. S., chapt. 9, pp. 149-153, 1990.
27. Dilley, W. G., Haagensen, D. E., Cox, C. E. and Wells, S. J.: Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid. Breast Cancer Res. Treat., 16: 253, 1990.
28. Epstein, J. I.: PSA and PAP as immunohistochemical markers in prostate cancer. Urol. Clin. North Am., 20: 757, 1993.
29. Rainbow, R. D.: Immunohistochemistry. In: Laboratory Histopathology; A Complete Reference. Edited by A. E. Woods and R. C. Ellis. Churchill Livingstone., chapt. 8, pp. 8.2-52-53, 1994.
30. Renan, M. J.: How may mutations are required for tumorigenesis?: Implications from human cancer data. Mol. Carcinogen., 7: 139, 1993.
31. Rinker-Schaeffer, C. W., Partin, A. W., Isaacs, W. B., Coffey, D. S. and Isaacs, J. T.: Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate, 25: 249, 1994.
32. Milne, R. W., Rassart, E. and Marcel, Y. L.: Molecular biology of apolipoprotein D. Curr. Opin. Lipidol., 4: 100, 1993.
33. Boyles, J. K., Notterpek, L. M. and Anderson, L. J.: Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J. Biol. Chem., 265: 17805, 1990.
34. Provost, P. R., Marcel, Y. L., Milne, R. W., Weech, P. K. and Rassart, E.: Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett., 290: 139, 1991.
35. Pertschuk, L. P., Schaeffer, H., Feldman, J. G., Macchia, R. J., Kim, Y-D., Eisenberg, K., Braithwaite, L. V., Axiotis, C. A., Prins, G. and Greene, G. L.: Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with poor prognosis. Lab. Invest., 73: 302, 1995.
36. Lu-Yao, G. L., McLerran, D., Wasson, J. H. and Wennberg, J. E.: An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA, 269: 2633, 1993.
37. Wasson, J. H., Cushman, C. C., Bruskewitz, R. C., Littenberg, B., Mulley, A. G., Jr. and Wennberg, J. E.: A structured literature review of treatment for localized prostate cancer. Prostate Disease Outcomes Research Team. Arch. Fam. Med., 2: 487, 1993.
38. Diez-Itza, I., Vizoso, F., Merino, A. M., Sanchez, L. M., Tolivia, J., Fernandez, J., Ruibal, A. and Lopez-Otin, C.: Expression and prognostic significance of apolipoprotein D in breast cancer. Am. J. Pathol., 144: 310, 1994.